Jiangyue Liu
Prior Academic Affiliations:
B.S., Huazhong University of Science and Technology, Tongji Medical College
M.S., University of Southern California, Keck School of Medicine
Thesis Mentor
Dr. Saul Priceman
Thesis Project
Fellowship, Honors, Awards etc.
Research/Professional Experiences:
Associate Scientist and Senior Research Associate, Preclinical and Translational Science, R&D, Atara Biotherapeutics, Inc.
Graduate Research Assistant, Prof. Pin Wang’s lab, USC
Undergrad Research Assistant, Prof. Hua Li’s lab, HUST
Undergrad Research Assistant, Prof. Ming Xiang’s lab, HUST
Publications:
Qu Y, Dunn Z, Chen X, ... Liu J, et al. Adenosine Deaminase 1 Overexpression Enhances the Antitumor Efficacy of CAR-engineered T Cells. Hum Gene Ther. 2021;10.1089.
Chen X, Yang S, Li S, ... Liu J, et al. Secretion of bispecific immune checkpoint-TGF-b trap protein enhances antitumor efficacy of chimeric antigen receptor-modified T cell therapy, Mol Ther Oncolytics. 2021;21:144-157.
Liu J, Chen X, Karlen J, et al. 98 ATA3271: an armored, next-generation off-the-shelf, allogeneic, mesothelin-CAR T cell therapy for solid tumors. Journal for ImmunoTherapy of Cancer 2020;8.
Qu Y, Siegler E, Cheng C, Liu J, et al. Engineering CAR-Expressing Natural Killer Cells with Cytokine Signaling and Synthetic Switch for an Off-the-Shelf Cell-Based Cancer Immunotherapy, MRS Communication, 2019;9(2):433-440.